1. Home
  2. IESC vs RARE Comparison

IESC vs RARE Comparison

Compare IESC & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IESC
  • RARE
  • Stock Information
  • Founded
  • IESC 1997
  • RARE 2010
  • Country
  • IESC United States
  • RARE United States
  • Employees
  • IESC N/A
  • RARE N/A
  • Industry
  • IESC Engineering & Construction
  • RARE Biotechnology: Pharmaceutical Preparations
  • Sector
  • IESC Industrials
  • RARE Health Care
  • Exchange
  • IESC Nasdaq
  • RARE Nasdaq
  • Market Cap
  • IESC 3.4B
  • RARE 3.6B
  • IPO Year
  • IESC 1998
  • RARE 2014
  • Fundamental
  • Price
  • IESC $165.11
  • RARE $36.21
  • Analyst Decision
  • IESC
  • RARE Strong Buy
  • Analyst Count
  • IESC 0
  • RARE 15
  • Target Price
  • IESC N/A
  • RARE $95.93
  • AVG Volume (30 Days)
  • IESC 192.8K
  • RARE 744.3K
  • Earning Date
  • IESC 05-02-2025
  • RARE 05-01-2025
  • Dividend Yield
  • IESC N/A
  • RARE N/A
  • EPS Growth
  • IESC 103.77
  • RARE N/A
  • EPS
  • IESC 10.74
  • RARE N/A
  • Revenue
  • IESC $2,999,461,000.00
  • RARE $560,230,000.00
  • Revenue This Year
  • IESC N/A
  • RARE $19.15
  • Revenue Next Year
  • IESC N/A
  • RARE $32.11
  • P/E Ratio
  • IESC $15.52
  • RARE N/A
  • Revenue Growth
  • IESC 23.09
  • RARE 29.01
  • 52 Week Low
  • IESC $112.73
  • RARE $35.53
  • 52 Week High
  • IESC $320.08
  • RARE $60.37
  • Technical
  • Relative Strength Index (RSI)
  • IESC 36.94
  • RARE 33.84
  • Support Level
  • IESC $176.97
  • RARE $36.71
  • Resistance Level
  • IESC $192.83
  • RARE $39.21
  • Average True Range (ATR)
  • IESC 9.62
  • RARE 1.33
  • MACD
  • IESC 0.18
  • RARE -0.11
  • Stochastic Oscillator
  • IESC 19.97
  • RARE 13.54

About IESC IES Holdings Inc.

IES Holdings Inc owns and manages subsidiaries that design and installs integrated electrical and technology systems and provide infrastructure products and services. It has four business segments; Communications, Residential, Infrastructure Solutions, and Commercial & Industrial. The majority of the revenue for the company is generated from its Residential segment in which the company provides electrical installation services for single-family housing and multi-family apartment complexes, as well as heating, ventilation, and air conditioning (HVAC) and plumbing installation services. This segment also provides services for installing residential solar power, both for new construction and existing residences.

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

Share on Social Networks: